Predict your next investment

Hemex Health company logo
HEALTHCARE | Disease Diagnosis
hemexhealth.com

See what CB Insights has to offer

Stage

Unattributed VC | Alive

Total Raised

$6.29M

Last Raised

$200K | 4 mos ago

About Hemex Health

Hemex creates affordable, life-changing medical diagnostics for under-served people everywhere. Its diagnostic platform is designed to reach populations at risk for malaria and sickle cell disease.

Hemex Health Headquarter Location

4640 SW Macadam Ave Ste. 250

Portland, Oregon, 97239,

United States

503-703-7696

Latest Hemex Health News

Mylab, Hemex partner to develop POC diagnostics for Covid-19

Aug 11, 2021

The companies will also focus on the development of Fluorescence Immunoassay and Electrophoresis-based diagnostic solutions Mylab will develop test assays under the partnership. (Credit: Ahmad Ardity from Pixabay) India-based biotechnology firm Mylab Discovery Solutions has collaborated with Hemex Health to develop next-generation diagnostic solutions for the Point-of-Care (POC) testing of coronavirus and other diseases. As part of the deal, Mylab will involve in the development of test assays, while US-based medical diagnostic device company Hemex will offer its Gazelle POC testing platform and expertise. The portable diagnostic device and test assays facilitate testing at any location, as well as in a wide range of environmental conditions. They also help to avoid the shipping of the sample and enable rapid result for the patients. Both companies will also focus on the development of Fluorescence Immunoassay (FIA) and Electrophoresis-based diagnostic solutions. These tests are said to be more sensitive than the normal rapid antigen tests and may result in less false negatives. Mylab and Hemex Health will jointly launch the diagnostic solution in international markets including the US, Europe and Asia. The partnership will also bring together deep knowledge in molecular diagnostic technology, product ideation, and new technology development and deployment to boost testing capabilities for Covid-19 across the world. Mylab and Hemex Health are planning to launch the first product from the technology partnership by November this year. Hemex Health, which is supported by TiE Global Angels and Cleveland Clinic, supplies a point-of-care sickle cell test on their Gazelle Diagnostic Device in nine countries. Supported by Adar Poonawalla of Serum Institute of India, Mylab is engaged in the development of diagnostics solutions. It already offers CoviSelf self-test kit for Covid-19. Do you have interesting content to share with us? Enter your email address so we can get in touch. Related Article

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Hemex Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Hemex Health is included in 4 Expert Collections, including Medical Devices.

M

Medical Devices

8,074 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. Excludes CDMOs/CMOs. *Columns updated as regularly as possible.

H

Health & Wellness Assessment

3,064 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

I

Infectious Disease

2,225 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Hemex Health Patents

Hemex Health has filed 10 patents.

The 3 most popular patent topics include:

  • Blood tests
  • Medical tests
  • Rare diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/25/2020

7/13/2021

Rare diseases, Transcription factors, Biotechnology, Syndromes, Digestive system

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/25/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

7/13/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Rare diseases, Transcription factors, Biotechnology, Syndromes, Digestive system

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Hemex Health Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Hemex Health Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.